What is Amphastar Pharmaceuticals's revenue?

Amphastar Pharmaceuticals (AMPH) generated $720.5M in revenue over the trailing twelve months, down 1.4% year over year.

Is Amphastar Pharmaceuticals profitable?

Amphastar Pharmaceuticals reported $79.2M in net income over the trailing twelve months, a 11.0% net margin.

What are Amphastar Pharmaceuticals's profit margins?

Gross margin is 47.3% and operating margin is 16.2%, with a 11.0% net margin.

What is Amphastar Pharmaceuticals's earnings per share?

Amphastar Pharmaceuticals's diluted EPS over the trailing twelve months is $1.66.

Where does Amphastar Pharmaceuticals's income statement data come from?

Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Amphastar Pharmaceuticals AMPH Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$720.53M-1.4%	$719.89M-1.7%	$723.31M0.0%	$722.68M+1.4%	$730.66M+8.1%
Total cost of revenue	$379.4M+4.9%	$363.83M+1.6%	$366.27M+7.7%	$362.35M+12.2%	$361.65M+17.1%
Gross profit	$341.13M-7.6%	$356.06M-4.8%	$357.04M-6.9%	$360.33M-7.6%	$369.01M+0.4%
Gross margin	47.3%-3.2pp	49.5%-1.6pp	49.4%-3.6pp	49.9%-4.8pp	50.5%-3.8pp
Research and development	$92.49M+20.2%	$85.84M+16.1%	$80.67M+5.9%	$79.4M+10.6%	$76.97M+8.5%
Selling and marketing	$43.95M+9.1%	$43.89M+16.1%	$44.03M+22.3%	$41.52M+24.3%	$40.3M+29.5%
General and administrative	$87.96M+54.2%	$85.93M+51.5%	$82.39M+44.8%	$57.75M+5.5%	$57.04M+6.2%
Total operating expenses	$224.39M+28.7%	$215.65M+28.0%	$207.09M+22.5%	$178.66M+11.7%	$174.3M+11.9%
Operating income	$116.74M-40.0%	$140.4M-31.7%	$149.94M-30.0%	$181.67M-21.0%	$194.7M-8.0%
Operating margin	16.2%-10.4pp	19.5%-8.6pp	20.7%-8.9pp	25.1%-7.1pp	26.6%-4.6pp
Interest expense	$25.75M-8.1%	$25.48M-16.0%	$25.28M-24.3%	$25.69M-36.4%	$28.02M-20.8%
Other income (expense), net	-$13.93M+36.6%	-$16.78M-7.2%	-$14.27M+47.4%	-$19.83M+26.0%	-$21.95M+15.2%
Income before income taxes	$102.81M-40.5%	$123.62M-34.9%	$135.67M-27.5%	$161.84M-20.3%	$172.75M-7.0%
Income tax expense	$23.59M-24.2%	$25.53M-14.0%	$24.04M-15.2%	$27.13M-22.7%	$31.12M+6.6%
Net income	$79.23M-44.1%	$98.09M-38.5%	$111.63M-29.2%	$134.71M-19.1%	$141.63M-8.4%
Net margin	11%-8.4pp	13.6%-8.2pp	15.4%-6.4pp	18.6%-4.7pp	19.4%-3.5pp
Diluted earnings per share	$1.66-39.9%	$2.03-33.7%	$2.26-24.9%	$2.67-15.0%	$2.76-4.8%
EBITDA	$174.17M-29.9%	$197.1M-23.7%	$205.73M-22.8%	$236.73M-15.9%	$248.3M-3.0%
EBITDA margin	24.2%-9.8pp	27.4%-7.9pp	28.4%-8.4pp	32.8%-6.7pp	34%-3.9pp
EBIT	$116.74M-40.0%	$140.4M-31.7%	$149.94M-30.0%	$181.67M-21.0%	$194.7M-8.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amphastar Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's revenue?: Amphastar Pharmaceuticals (AMPH) generated $720.5M in revenue over the trailing twelve months, down 1.4% year over year.
Is Amphastar Pharmaceuticals profitable?: Amphastar Pharmaceuticals reported $79.2M in net income over the trailing twelve months, a 11.0% net margin.
What are Amphastar Pharmaceuticals's profit margins?: Gross margin is 47.3% and operating margin is 16.2%, with a 11.0% net margin.
What is Amphastar Pharmaceuticals's earnings per share?: Amphastar Pharmaceuticals's diluted EPS over the trailing twelve months is $1.66.
Where does Amphastar Pharmaceuticals's income statement data come from?: Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.